100%. There will be strict quotas on the expensive models and day to day work will be done on the cheap models that are "good enough" with escalation to the metered models when the cheaper options are spinning their wheels. Eventually the US frontier lab APIs will only get the most heavily triaged work that multiple tiers of cheaper Chinese open weight models have failed on.

And of course the C-suite will have unlimited access to Mythos tier models, which they'll use to summarize reports, while passing down mandates to rank and file to increase usage of less expensive models.